Global Health Reports Strong Q1 FY2026 Results, Announces Key Board Reappointments
Global Health Limited, operator of Medanta hospitals, reported robust Q1 FY2026 results with consolidated revenue reaching ₹10,308.37 crore and profit after tax of ₹1,589.82 crore. The Board recommended reappointments of Dr. Naresh Trehan as Chairman and Managing Director, and Mr. Vikram Singh Mehta and Mr. Hari Shanker Bhartia as Independent Directors. The company scheduled its 21st AGM for September 19, 2025, and set a record date for a final dividend of ₹0.50 per share. Global Health also received a land offer in Guwahati for a potential super specialty hospital and approved an employee stock option plan.

*this image is generated using AI for illustrative purposes only.
Global Health Limited , the operator of Medanta hospitals, has reported robust financial performance for the first quarter of fiscal year 2026, alongside significant corporate governance updates.
Financial Highlights
Global Health's consolidated revenue from operations for Q1 FY2026 reached ₹10,308.37 crore, marking a substantial increase from ₹8,610.77 crore in the same quarter last year. The company's profit after tax surged to ₹1,589.82 crore, up from ₹1,062.64 crore year-over-year.
On a standalone basis, the company reported revenue from operations of ₹8,821.56 crore, compared to ₹7,578.62 crore in Q1 FY2025. Standalone profit after tax increased to ₹1,519.64 crore from ₹1,085.51 crore in the corresponding quarter of the previous year.
Key Corporate Developments
The Board of Directors has recommended several significant reappointments:
Dr. Naresh Trehan has been recommended for reappointment as Chairman and Managing Director for a five-year term starting August 1, 2026.
Mr. Vikram Singh Mehta and Mr. Hari Shanker Bhartia have been recommended for reappointment as Independent Directors for second terms of five consecutive years, effective January 25, 2026, and March 23, 2026, respectively.
Dividend and AGM Announcement
Global Health has scheduled its 21st Annual General Meeting (AGM) for September 19, 2025, to be held via video conferencing. The company has set August 22, 2025, as the record date for determining shareholder eligibility for a final dividend of ₹0.50 per equity share for FY2025, subject to shareholder approval at the AGM.
Expansion Plans
During the quarter, Global Health received an offer from Assam Electricity Grid Corporation Limited to acquire a land parcel in Guwahati for establishing a super specialty hospital. The company has subsequently received a revised offer for a 3.5-acre land parcel, indicating potential expansion plans in the northeastern region.
Employee Stock Option Plan
The company has approved the grant of 595,500 options to eligible employees under the Global Health Limited Employees Long-Term Share Based Incentive Plan - 2024. Additionally, 163,000 shares have been allotted to the GHL Employees Welfare Trust as part of this plan.
Global Health's strong financial performance and strategic initiatives demonstrate its commitment to growth and corporate governance, positioning it well for future expansion in the healthcare sector.
Historical Stock Returns for Global Health
1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|
+7.25% | +6.41% | +16.84% | +25.80% | +21.23% | +242.69% |